New hope for kids with devastating brain cancer: trial tests 'Living Drug' made from their own cells
NCT ID NCT03396575
Summary
This early-stage trial tested a personalized treatment for children with a rare and aggressive brain tumor called DIPG. The goal was to see if a patient's own immune cells, trained to attack their tumor, could be safely given after radiation therapy. Researchers wanted to learn if this approach could help control the disease and improve survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN STEM GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UF Health Shands Children's Hospital
Gainesville, Florida, 32610, United States
Conditions
Explore the condition pages connected to this study.